Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events.

Chan AT, Manson JE, Albert CM, Chae CU, Rexrode KM, Curhan GC, Rimm EB, Willett WC, Fuchs CS.

Circulation. 2006 Mar 28;113(12):1578-87.

2.

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.

Arthritis Rheum. 2006 May;54(5):1378-89.

3.

Use of acetaminophen and nonsteroidal anti-inflammatory drugs: a prospective study and the risk of symptomatic diverticular disease in men.

Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Willett WC.

Arch Fam Med. 1998 May-Jun;7(3):255-60.

PMID:
9596460
5.

Frequency of analgesic use and risk of hypertension in younger women.

Curhan GC, Willett WC, Rosner B, Stampfer MJ.

Arch Intern Med. 2002 Oct 28;162(19):2204-8.

PMID:
12390063
6.

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Rostom A, Dubé C, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D; U.S. Preventive Services Task Force..

Ann Intern Med. 2007 Mar 6;146(5):376-89. Review.

PMID:
17339623
8.

Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.

Roumie CL, Choma NN, Kaltenbach L, Mitchel EF Jr, Arbogast PG, Griffin MR.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1053-63. doi: 10.1002/pds.1820.

PMID:
19637402
9.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

10.

Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.

Haag MD, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH.

Arch Intern Med. 2008 Jun 9;168(11):1219-24. doi: 10.1001/archinte.168.11.1219.

PMID:
18541831
12.

Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.

Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Køber L, Madsen M, Torp-Pedersen C.

Circulation. 2006 Jun 27;113(25):2906-13.

13.

Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs.

Hermann M.

Curr Rheumatol Rep. 2009 Feb;11(1):31-5. Review.

PMID:
19171109
14.

Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population.

Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD.

Arch Intern Med. 2005 Jan 24;165(2):181-6.

PMID:
15668364
15.

The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.

van der Linden MW, van der Bij S, Welsing P, Kuipers EJ, Herings RM.

Ann Rheum Dis. 2009 May;68(5):668-73. doi: 10.1136/ard.2007.087254.

PMID:
18495734
16.

A prospective study of aspirin use and the risk of pancreatic cancer in women.

Schernhammer ES, Kang JH, Chan AT, Michaud DS, Skinner HG, Giovannucci E, Colditz GA, Fuchs CS.

J Natl Cancer Inst. 2004 Jan 7;96(1):22-8.

17.

Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.

White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, Weiner E, Verburg KM.

Am J Cardiol. 2007 Jan 1;99(1):91-8.

PMID:
17196469
18.

Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.

Joshi GP, Gertler R, Fricker R.

Anesth Analg. 2007 Dec;105(6):1793-804, table of contents. Review.

PMID:
18042885
Items per page

Supplemental Content

Support Center